Compare BNR & CHMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNR | CHMG |
|---|---|---|
| Founded | 2014 | 1833 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.6M | 242.8M |
| IPO Year | 2020 | N/A |
| Metric | BNR | CHMG |
|---|---|---|
| Price | $21.26 | $55.05 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $54.50 |
| AVG Volume (30 Days) | ★ 66.8K | 10.7K |
| Earning Date | 11-20-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 2.47% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.80 |
| Revenue | $75,749,382.00 | ★ $86,610,000.00 |
| Revenue This Year | $136.32 | N/A |
| Revenue Next Year | N/A | $32.65 |
| P/E Ratio | ★ N/A | $19.68 |
| Revenue Growth | ★ 5.56 | N/A |
| 52 Week Low | $2.18 | $40.71 |
| 52 Week High | $24.18 | $60.80 |
| Indicator | BNR | CHMG |
|---|---|---|
| Relative Strength Index (RSI) | 56.39 | 48.87 |
| Support Level | $19.49 | $53.83 |
| Resistance Level | $24.18 | $60.80 |
| Average True Range (ATR) | 1.90 | 1.41 |
| MACD | 0.05 | -0.27 |
| Stochastic Oscillator | 56.56 | 29.36 |
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.